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AbstrAct
Hypertension is a modifiable risk factor for cardiovascular disease and death. On a 
worldwide scale, it is estimated that over 1 billion adult individuals are afflicted by hy-
pertension, and hypertension is responsible for over 9 million deaths annually. Among 
dietary strategies to counter this epidemic, principal role has been assigned to reduc-
ing dietary sodium which has been included in many guidelines for the treatment of 
hypertension and prevention of cardiovascular disease. However, recent studies have 
raised questions about potential harmful effects associated with low sodium intake. 
Ensuing the tumult stirred by these studies reporting on the role of salt intake restric-
tion on blood pressure and cardiovascular mortality, we are herein providing a brief 
overview of the topic. Despite the “controversy’, the data appear compelling toward 
the need for reducing salt intake as one of the most cost-effective measures to control 
blood pressure and reduce cardiovascular disease worldwide at the population level. 
INtrODUctION
Hypertension is a modifiable risk factor for cardiovascular disease and death. On 
a worldwide scale, it is estimated that over 1 billion adult individuals are afflicted by 
hypertension, and hypertension is responsible for over 9 million deaths annually.1,2 
Hypertension affects 1 in 4 adults worldwide. 
Apropos with the most recent studies examining the role of sodium in blood pres-
sure control and the association of salt intake with hypertension and cardiovascular 
mortality,3-6 we attempt to provide an overview of this important topic. 
rOLE OF sODIUM
Sodium appears to play a key role in blood pressure control. Salt intake influences 
cardiovascular morbidity and mortality mainly because of its positive association with 
blood pressure. In the 1980s, the INTERSALT study indicated that populations with 
low dietary salt intake (i.e., <3 g/24h or 1.1 g of sodium/24h) presented a lower blood 
pressure increase with age and that the increase in systolic blood pressure with age 
was linked to dietary salt intake.7 In the 1990s, an overview of data collected for 47,000 
non-African individuals from 24 communities showed a positive and age-dependent 
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association between blood pressure and urinary sodium 
excretion across and within populations.8,9 In the 2000s, in 
the INTERMAP study, the difference in the blood pressure 
between the populations in Northern and Southern China, 
was found to be partly due to dietary salt intake.10 In the past 
30 years, a large number of randomized controlled trials have 
analyzed the effect of reducing salt intake on blood pressure.11 
Most trials examined the effect of short-term salt reduction. 
Salt reductions of 4-6 g per day significantly reduce systolic/
diastolic blood pressure both in hypertensive (~3-5/1-2 mm 
Hg) and in normotensive individuals (~1-2/0-1 mm Hg). Such 
small reductions are expected, if sustained and applied to 
the general population, to lead to a substantial reduction in 
cardiovascular events.11 
Thus, among dietary strategies to counter this hyperten-
sion epidemic, principal role has been assigned to reducing 
dietary sodium at the population level as one of the most 
cost-effective public health strategies worldwide. Dietary 
salt reduction has been included in many guidelines for the 
treatment of hypertension and prevention of cardiovascular 
disease. The World Health Organization (WHO) recommends 
“salt reduction through mass-media campaigns and reduced 
salt content in processed foods”; “adults should consume <2 
grams of sodium, or <5 g of salt per day”1 [most sodium is 
consumed in the form of sodium chloride (salt); amount of 
sodium multiplied by the factor 2.5 gives the equivalent amount 
of salt]. However, recent studies have raised questions about 
potential harmful effects associated with low sodium intake.3-5,12 
PUrE AND NUtrIcODE stUDIEs
The Prospective Urban Rural Epidemiology (PURE) study 
was a large epidemiological study which followed 156,424 
persons, aged 35-70 years, from 628 urban and rural commu-
nities in 17 low-, middle-, and high-income countries.3,4 The 
investigators used as a surrogate for salt intake an estimated 
24-hour sodium excretion by obtaining morning fasting urine 
samples; in the same samples they also estimated 24-hour 
potassium excretion. 
In one report, they examined the relationship between 
sodium and potassium excretion and blood pressure measured 
with an automated device in 102,216 adults from 18 countries.3 
Regression analyses showed increments of 2.11 mm Hg in 
systolic blood pressure and 0.78 mm Hg in diastolic blood 
pressure for each 1-g increment in estimated sodium excre-
tion. This association was proportional to sodium excretion 
with a steeper slope with higher sodium intake (an increment 
of 2.58 mm Hg in systolic blood pressure per gram for sodium 
excretion >5 g per day, 1.74 mm Hg per gram for 3 to 5 g per 
day, and 0.74 mm Hg per gram for <3 g per day; P<0.001 
for interaction). The slope of association was also steeper for 
hypertensive individuals (2.49 mm Hg per gram) compared 
with non-hypertensives (1.30 mm Hg per gram, P<0.001 for 
interaction) and for older persons (2.97 mm Hg per gram at 
>55 years of age, 2.43 mm Hg per gram at 45 to 55 years of age, 
and 1.96 mm Hg per gram at <45 years of age; P<0.001 for 
interaction). Potassium excretion was inversely associated with 
systolic blood pressure, with a steeper slope of association for 
hypertensive vs non-hypertensive persons (P<0.001) and older 
ages (P<0.001). The authors concluded that the association of 
estimated intake of sodium with blood pressure was nonlinear 
and was most pronounced in persons consuming high-sodium 
diets, hypertensive individuals, and older persons; a significant 
inverse association with systolic blood pressure was found for 
estimated potassium excretion, with steep slopes of association 
among persons with hypertension, older, and obese persons. 
In a second report the PURE study investigators examined 
the association between estimated urinary sodium and potas-
sium excretion and outcome of death and major cardiovascular 
events.4 The mean estimated sodium excretion was 4.93 g per 
day and potassium excretion was 2.12 g per day. With a mean 
follow-up of 3.7 years, death or cardiovascular events occurred 
in 3317 participants (3.3%). A higher estimated sodium excre-
tion (≥7.00 g per day) was associated with an increased risk 
(odds ratio, 1.15), compared with an estimated sodium excre-
tion of 4-6 g per day (reference range). The association was 
strongest among participants with hypertension (P = 0.02 for 
interaction), having an increased risk at an estimated sodium 
excretion of >6 g per day. Interestingly, a low estimated 
sodium excretion <3 g per day was also associated with an 
increased risk of the composite outcome (odds ratio, 1.27). 
On the other hand, higher potassium excretion was associated 
with a reduced risk of the composite outcome. The authors 
concluded that an estimated sodium intake between 3 g per 
day and 6 g per day was associated with a lower risk of death 
and cardiovascular events than was either a higher or lower 
estimated level of intake; higher potassium excretion was as-
sociated with a lower risk of death and cardiovascular events.
A major limitation of the PURE study, by the authors’ 
own admission, is that their validated method of estimating 
sodium and potassium intake used a formula-derived estimate 
of 24-hour urinary excretion which is less reliable compared to 
actual 24-hour urinary collection.3,4,6,13 The major criticism is 
directed against the provocative finding that low (in addition to 
high) levels of sodium excretion may be also associated with an 
increased risk of death and cardiovascular-disease outcomes. 
All agree that the associated risk is high with high sodium 
intake, but most disagree with the notion that this may also 
hold true with low sodium levels. The latter finding was further 
refuted by the second study reported in the same issue of the 
New England Journal of Medicine, the NUTRICODE study.5 
The NUTRICODE study, part of the Global Burden 
of Diseases Nutrition and Chronic Diseases Expert Group, 
collected data from surveys on sodium intake determined by 
urinary excretion and diet in persons from 66 countries and 
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used these data to quantify the global consumption of sodium 
according to age, gender, and country.5 The effects of sodium 
on blood pressure, according to age, race, and the presence or 
absence of hypertension, were calculated from data in a new 
meta-analysis of 107 randomized interventions, and the effects 
of blood pressure on cardiovascular mortality, according to 
age, were calculated from a meta-analysis of cohorts. Using 
comparative risk assessment, the investigators estimated the 
cardiovascular effects of current sodium intake, as compared 
with a reference intake of 2.0 g of sodium per day, according to 
age, sex, and country. In 2010, the estimated mean level of global 
sodium consumption was 3.95 g per day, and regional mean 
levels ranged from 2.18 to 5.51 g per day. Globally, 1.65 million 
annual deaths from cardiovascular causes were attributed to 
sodium intake above the reference level; 62% of these deaths 
occurred in men and 38% occurred in women. These deaths 
accounted for nearly 1 of every 10 deaths from cardiovascular 
causes (9.5%). Four of every 5 deaths (84.3%) occurred in low- 
and middle-income countries, and 2 of every 5 deaths (40.4%) 
occurred prematurely (before 70 years of age). Although the 
rate of death from cardiovascular causes associated with sodium 
intake above the reference level was highest in Central Asia and 
lowest in Kenya, it remained high (>750 deaths per 1 million 
adults aged ≥70 years) in all regions. The meta-analysis showed 
a linear dose–response relationship between reduced sodium 
intake and blood pressure, jointly modified according to age, 
race, and the presence or absence of hypertension. The authors 
concluded that in this modeling study, 1.65 million deaths from 
cardiovascular causes that occurred in 2010 were attributed to 
sodium consumption greater than 2 g per day. 
G L O b A L  A P P r O A c H
The WHO recommends sodium reduction <2 g/day or salt 
reduction to ≤5 g/day.1 These new data from PURE provide 
no reasons to change this recommendation.3,4 NUTRICODE 
provided data on the effects of sodium consumption on 
blood pressure and cardiovascular risk.5 The Global Burden 
of Disease data highlight the need for governments and the 
food industry to intensify their efforts to reduce salt in our 
diets. Although precise targets for sodium reduction remain 
controversial, various organizations having reviewed the exist-
ing evidence have proposed target levels from 1.2 to 2.4 g per 
day. Any suggestion that national or international guidelines 
should be changed on the basis of the PURE data is contrary 
to global best practice. Randomized trials of salt reduction 
show clear benefits on blood pressure, the leading cause of 
premature death in the world. This is the best evidence we have 
to date and it’s the evidence that should guide health policy.
During the joint conference (Hypertension 2014) of the 
European and International Societies of Hypertension in Ath-
ens in June 2014, it was pointed out that any “controversy” over 
whether dietary salt is a cause of heart disease and stroke is the 
result of weak research methodology or industry interference 
(www.medscape.com).13 Most researchers dismissed the use of 
spot urine analyses as a means of estimating sodium consump-
tion, which was the method employed in the PURE study.1.2 
The researchers emphasized the striking statistic that a 2-g 
drop in the amount of salt consumed per day would translate 
into a 20% reduction in cardiovascular events. Citing a 2010 
Institute of Medicine (IOM) report (http://www.iom.edu), Dr 
Campbell stated that approximately 32% of hypertension cases 
are caused by high dietary salt—a number that translates into 
about 300 million people. The same researcher indicated that 
the “Global Burden of Disease study estimates over 3 million 
deaths, 61 million years of disability, and 57 million years of 
life lost, all related to high dietary salt in 2010, which is really 
a massive and catastrophic public-health problem”.
Reducing population salt intake requires measures from all 
parties involved, including the government, the food industry, 
non-governmental organizations, health professionals and the 
public.1,14,15 According to WHO and European Union (EU), 
several countries have successfully carried out salt reduc-
tion programs as a result of which salt intake has fallen.1,15 A 
reduction in salt intake contributed to the reduction of mor-
tality from heart disease and stroke in Finland. The United 
Kingdom, the United States and several other high-income 
countries have also successfully developed programs of vol-
untary salt reduction in collaboration with the food industry. 
A new study, published in BMJ Open,14 determined the 
relationship between the reduction in salt intake that occurred 
in England, and blood pressure and cardiovascular mortality, 
by analyzing the data from the Health Survey for England 
between 2003 and 2011. According with these findings, there 
was a decrease in mortality from stroke by 42% (p<0.001) 
and ischemic heart disease by 40% (p<0.001). At the same 
time, there was a reduction in blood pressure of 3.0±0.33/ 
1.4±0.20 mmHg (p<0.001/p<0.001), a decrease of 0.4 ±0.02 
mmol/L (p<0.001) in cholesterol, a reduction in smoking 
prevalence from 19% to 14% (p<0.001), an increase in fruit 
and vegetable consumption (0.2±0.05 portion/day, p<0.001) 
and an increase in body mass index (BMI; 0.5±0.09 kg/m2, 
p<0.001). Salt intake, as measured by 24 h urinary sodium, 
decreased by 1.4g/day (p<0.01) (15% drop). The authors 
concluded that a 15% reduction in daily salt intake was likely 
an important contributor to the reductions in blood pressure 
from 2003 to 2011 in England, which further conferred a re-
duction in stroke and ischemic heart disease mortality during 
this period. Despite considerable progress being made on salt 
reduction, the mean salt intake in England (8.1 g/day in 2011) 
was still 35% higher than the recommended level of 6 g/day, 
and 70% of the adult population had a daily salt intake above 
the recommended level. 
The WHO report indicates that sodium content is high in 
processed foods, such as bread (~250 mg/100 g), processed 
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meats like bacon (~1500 mg/100 g), snack foods such as pret-
zels, cheese puffs and popcorn (~1500 mg/100 g), as well as 
in condiments (seasoning/flavoring) such as soy sauce (~7000 
mg/100 g), and bouillon or stock cubes (~20 000 mg/100 g).1 
The EU report blames bread, meat and meat products and 
dairy products (including cheese), ready meals and soups as the 
most important sources of salt in the national diet of most EU 
countries.15 On the other hand, potassium-rich food helps to 
reduce blood pressure. WHO recommends that adults should 
consume ≥3,510 mg of potassium/day. Potassium-rich foods 
include beans and peas (~1,300 mg of potassium per 100 g), 
nuts (~600 mg/100 g), vegetables such as spinach, cabbage and 
parsley (~550 mg/100 g) and fruit such as bananas, papayas 
and dates (~300 mg/100 g).1 Processing reduces the amount 
of potassium in many food products.
c O N c L U s I O N
Although the new studies (PURE and NUTRICODE)3-5 
stirred some controversy about the importance of salt intake 
in controlling blood pressure and affecting cardiovascular 
mortality, the evidence for the significant role of salt intake in 
this epidemic remains strong and should not lead us to deviate 
from the primary goal of reducing dietary salt intake, while 
at the same time increasing dietary potassium, as a means to 
counter the adverse effects of hypertension on cardiovascular 
disease and population health, in general.1,15,16 
On the average, salt intake remains excessive in most popu-
lations (with the majority ranging between 8 and 12 grams of 
salt per day) and several countries have started to implement 
population-based strategies to reduce it.15 There is dire need 
to observe and comply with the WHO recommended values 
(<2 grams of sodium or <5 grams of salt per day). Despite the 
“controversy”, there is considerable benefit of salt reduction 
effected via reduced blood pressure and cardiovascular events, 
and it appears that the worry of doing harm is negligible or 
absent.11,16 Furthermore, there appears to be evidence that 
high salt intake is also likely associated with diseases other 
than cardiovascular disease (such as gastric cancer, obesity 
and osteoporosis).17-20 Thus, the strategy of limiting dietary salt 
intake is considered as one of the most cost-effective public 
health strategies worldwide and should be applied through 
legislation at both the industry and the consumer levels.1,11,15,16 
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